Adaptive and Individualized AAC Phase II

Part of paid clinical trials in Omaha, Nebraska.

Sponsor
Altec Inc.
Study ID
NCT06337188
Status
Recruiting
Apply to this trial

Conditions

  • Communication Disorders

Eligibility Criteria

Sex
ALL
Age
6 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Experimental AAC — DEVICE
    Participant receives an AAC system comprising 2 wearable sensors for movement-mediated cursor control and muscle activity mediated cursor selection that is integrated with an adaptive and individualized keyboard to test communication performance.
  • Generic AAC — DEVICE
    Participant receives an AAC system that is similar to that used to satisfy their normal daily communication needs such as an eye-tracking device with a generic AAC keyboard to test communication.

Study Details

The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.

Key Dates

Start date
Dec 3, 2024
Status verified
Sep 2025
Primary completion
Mar 1, 2026
Completion
Mar 1, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Experimental and Generic Communication Interfaces for AAC
    Each participant receives both Experimental and Generic AAC systems to communicate - in that order.

Primary Outcome Measure

Tele-healthcare Satisfaction Questionnaire - Wearable Technology (TSQ-WT) [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Nebraska Medical CenterOmahaNebraska68198
Susan Fager, Ph.D.
[email protected]
402-559-0426
Jessica Gormley, Ph.D.
[email protected]
402-559-6460

Find similar trials in Omaha, NE

By research site
University of Nebraska Medical Center· Omaha, NE

Related Studies